低剂量布地奈德/福莫特罗可对抗慢性阻塞性肺疾病中的气道炎症并改善肺功能。 - Suppr

Suppr

超能文献

Low-Dose Budesonide/Formoterol Counteracts Airway Inflammation and Improves Lung Function in Chronic Obstructive Pulmonary Disease.

作者信息

Hakim Amir, Khan Younis, Esteban Ignacio, Meah Sally, Miller-Larsson Anna, Barnes Peter J, Usmani Omar S

机构信息

1 Imperial College London London, United Kingdom and.

2 AstraZeneca Gothenburg Mölndal, Sweden.

出版信息

Am J Respir Crit Care Med. 2019 Mar 1;199(5):662-664. doi: 10.1164/rccm.201808-1590LE.

DOI:10.1164/rccm.201808-1590LE

PMID:30540486

Abstract

摘要

相似文献

Low-Dose Budesonide/Formoterol Counteracts Airway Inflammation and Improves Lung Function in Chronic Obstructive Pulmonary Disease.低剂量布地奈德/福莫特罗可对抗慢性阻塞性肺疾病中的气道炎症并改善肺功能。

Am J Respir Crit Care Med. 2019 Mar 1;199(5):662-664. doi: 10.1164/rccm.201808-1590LE.

Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study.布地奈德/福莫特罗干粉吸入剂对慢性阻塞性肺疾病急性加重的影响与福莫特罗相比：6 个月，随机 RISE（揭示 Symbicort 在减少 COPD 急性加重中的影响）研究。

Respir Med. 2017 Nov;132:31-41. doi: 10.1016/j.rmed.2017.09.002. Epub 2017 Sep 5.

Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD.采用创新共悬浮给药技术的布地奈德/富马酸福莫特罗定量吸入器在中重度慢性阻塞性肺疾病患者中的疗效、安全性和药代动力学

Int J Chron Obstruct Pulmon Dis. 2018 May 8;13:1483-1494. doi: 10.2147/COPD.S164281. eCollection 2018.

Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trial.在 COPD 中用布地奈德/福莫特罗降低肺过度充气的代谢和心肺影响：一项随机、双交叉、安慰剂对照、多中心试验。

Respir Res. 2020 Jan 20;21(1):26. doi: 10.1186/s12931-020-1288-3.

Onset of action of budesonide/formoterol Spiromax(®) compared with budesonide/formoterol Turbuhaler(®) in patients with COPD.布地奈德/福莫特罗准纳器（®）与布地奈德/福莫特罗都保（®）在慢性阻塞性肺疾病患者中的起效时间比较。

Pulm Pharmacol Ther. 2016 Aug;39:48-53. doi: 10.1016/j.pupt.2016.06.006. Epub 2016 Jun 22.

The Efficacy of N-Acetylcysteine Combined With Budesonide/Formoterol in the Treatment of Stable Chronic Obstructive Pulmonary Disease.

Am J Ther. 2022;29(6):e687-e690. doi: 10.1097/MJT.0000000000001290. Epub 2021 Jan 29.

Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial.在中度至重度稳定 COPD 成年患者中，以 Discair 干粉吸入递送的 12/400-µg 福莫特罗/布地奈德单剂量组合的支气管扩张剂疗效：开放标签、单臂、IV 期试验。

Clin Drug Investig. 2019 Oct;39(10):991-1001. doi: 10.1007/s40261-019-00828-y.

Clinical, physiological, and radiological features of asthma-chronic obstructive pulmonary disease overlap syndrome.哮喘-慢性阻塞性肺疾病重叠综合征的临床、生理及放射学特征

Int J Chron Obstruct Pulmon Dis. 2015 May 15;10:947-54. doi: 10.2147/COPD.S80022. eCollection 2015.

Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease.使用慢性阻塞性肺疾病患者的吸入谱，从 Spiromax®干粉吸入器中的中高剂量固定剂量组合中测量布地奈德和福莫特罗的实际剂量排放。

Eur J Pharm Sci. 2019 Nov 1;139:105059. doi: 10.1016/j.ejps.2019.105059. Epub 2019 Aug 28.

Real life dose emission characterization using COPD patient inhalation profiles when they inhaled using a fixed dose combination (FDC) of the medium strength Symbicort Turbuhaler.使用中强度 Symbicort Turbuhaler 固定剂量组合（FDC）吸入时，使用 COPD 患者吸入特征进行真实生活剂量发射特性描述。

Int J Pharm. 2017 Apr 30;522(1-2):137-146. doi: 10.1016/j.ijpharm.2017.02.057. Epub 2017 Feb 28.

引用本文的文献

Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids.布地奈德/格隆溴铵/富马酸福莫特罗和格隆溴铵/富马酸福莫特罗定量吸入器在 COPD 患者中的功能呼吸成像评估：吸入皮质类固醇的价值。

Respir Res. 2021 Jul 1;22(1):191. doi: 10.1186/s12931-021-01772-2.

Consistent Pulmonary Drug Delivery with Whole Lung Deposition Using the Aerosphere Inhaler: A Review of the Evidence.使用 Aerosphere 吸入器实现全肺沉积的一致肺部药物输送：证据回顾。

Int J Chron Obstruct Pulmon Dis. 2021 Jan 18;16:113-124. doi: 10.2147/COPD.S274846. eCollection 2021.

Measuring airway clearance outcomes in bronchiectasis: a review.支气管扩张症气道清除效果的测量：综述。

Eur Respir Rev. 2020 Apr 29;29(156). doi: 10.1183/16000617.0161-2019. Print 2020 Jun 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验